BAP31 Modulates Mitochondrial Homeostasis Through PINK1/Parkin Pathway in MPTP Parkinsonism Mouse Models
Cells · 2026
DOI: 10.3390/cells15020137 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Wanting Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Science and Health, Northeastern University, Shenyang 110169, China. Hauptthemen laut MEDLINE: Mitochondria, Protein Kinases, Ubiquitin-Protein Ligases, Homeostasis. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China.
Abstract (Originalsprache)
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by age-dependent degeneration of dopaminergic neurons in the substantia nigra, a process mediated by α-synuclein aggregation, mitochondrial dysfunction, and impaired proteostasis. While BAP31—an endoplasmic reticulum protein critical for protein trafficking and degradation—has been implicated in neuronal processes, its role in PD pathogenesis remains poorly understood. To investigate the impact of BAP31 deficiency on PD progression, we generated dopamine neuron-specific BAP31 conditional knockout with DAT-Cre (cKO) mice (Slc6a3cre-BAP31fl/fl) and subjected them to MPTP-lesioned Parkinsonian models. Compared to BAP31fl/fl controls, Slc6a3cre-BAP31fl/fl mice exhibited exacerbated motor deficits following MPTP treatment, including impaired rotarod performance, reduced balance beam traversal time, and diminished climbing and voluntary motor capacity abilities. BAP31 conditional deletion showed no baseline phenotype, with deficits emerging only after MPTP. Our results indicate that these behavioral impairments correlated with neuropathological hallmarks: decreased NeuN neuronal counts, elevated GFAP astrogliosis, reduced tyrosine hydroxylase levels in the substantia nigra, and aggravated dopaminergic neurodegeneration. Mechanistically, BAP31 deficiency disrupted mitochondrial homeostasis by suppressing the PINK1–Parkin mitophagy pathway. Further analysis revealed that BAP31 regulates PINK1 transcription via the transcription factor Engrailed Homeobox 1. Collectively, our findings identify BAP31 as a neuroprotective modulator that mitigates PD-associated motor dysfunction by preserving mitochondrial stability, underscoring its therapeutic potential as a target for neurodegenerative disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Science and Health, Northeastern University, Shenyang 110169, China.
- Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, Jiangsu Ocean University, Lianyungang 222005, China.
ORCID-Profile: Bing Wang
Förderung
- the National Natural Science Foundation of China
Zitieren
APA
Zhang, W., Meng, S., Hao, Z., Zhu, X., Cao, L., Yuan, Q., & Wang, B. (2026). BAP31 Modulates Mitochondrial Homeostasis Through PINK1/Parkin Pathway in MPTP Parkinsonism Mouse Models. Cells. https://doi.org/10.3390/cells15020137
Vancouver
Zhang W, Meng S, Hao Z, Zhu X, Cao L, Yuan Q, et al. BAP31 Modulates Mitochondrial Homeostasis Through PINK1/Parkin Pathway in MPTP Parkinsonism Mouse Models. Cells. 2026. doi:10.3390/cells15020137
BibTeX
@article{Zhang2026,
author = {Zhang, Wanting and Meng, Shihao and Hao, Zhenzhen and Zhu, Xiaoshuang and Cao, Lingwei and Yuan, Qing and Wang, Bing},
title = {BAP31 Modulates Mitochondrial Homeostasis Through PINK1/Parkin Pathway in MPTP Parkinsonism Mouse Models},
journal = {Cells},
year = {2026},
doi = {10.3390/cells15020137}
}
EUVIMED